CAdd image
Cartalax
HealingSingleAlso known as: Ala-Glu-Asp-Leu
A Khavinson bioregulator marketed for cartilage and connective-tissue support in age-related joint issues.
Half-life
—
Common dose
10 – 20 mg
Dosing frequency
Daily
Administration
Subcutaneous
How it works
Theorized to act as a tissue-specific bioregulator supporting chondrocyte gene expression and cartilage maintenance.
Protocol notes
Typical protocols: 10–20 mg subcutaneously daily for 10–20 days, cycled 2–3 times per year.
Reported side effects
Reported as well-tolerated.